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HUMAN DEVELOPMENT RESEARCH ARTICLE
The long non-coding RNA ROCR contributes to SOX9 expression
and chondrogenic differentiation of human mesenchymal stem
cells
Matt J. Barter1,*, Rodolfo Gomez2, Sam Hyatt3, Kat Cheung1, Andrew J. Skelton1, Yaobo Xu1, Ian M. Clark4 and
David A. Young1,*
ABSTRACT
Long non-coding RNAs (lncRNAs) are expressed in a highly tissue-
specific manner and function in various aspects of cell biology, often
as key regulators of gene expression. In this study, we established a
role for lncRNAs in chondrocyte differentiation. Using RNA
sequencing we identified a human articular chondrocyte repertoire
of lncRNAs from normal hip cartilage donated by neck of femur
fracture patients. Of particular interest are lncRNAs upstream of
the master chondrocyte transcription factor SOX9 locus. SOX9
is an HMG-box transcription factor that plays an essential role
in chondrocyte development by directing the expression of
chondrocyte-specific genes. Two of these lncRNAs are upregulated
during chondrogenic differentiation of mesenchymal stem cells
(MSCs). Depletion of one of these lncRNAs, LOC102723505,
which we termed ROCR (regulator of chondrogenesis RNA), by
RNA interference disrupted MSC chondrogenesis, concomitant with
reduced cartilage-specific gene expression and incomplete matrix
component production, indicating an important role in chondrocyte
biology. Specifically, SOX9 induction was significantly ablated in the
absence of ROCR, and overexpression of SOX9 rescued the
differentiation of MSCs into chondrocytes. Our work sheds further
light on chondrocyte-specific SOX9 expression and highlights a novel
method of chondrocyte gene regulation involving a lncRNA.
KEY WORDS: SOX9, LncRNA, Cartilage, Chondrogenesis, MSC,
Epigenetics, Differentiation
INTRODUCTION
Tens of thousands of long non-coding RNAs (lncRNAs) have been
identified in the human genome through the use of RNA deep
sequencing (RNA-Seq) (Iyer et al., 2015). lncRNAs are classified as
>200-nucleotide RNAs that derive from both intergenic and
overlapping protein-coding gene regions (Derrien et al., 2012).
Detailed studies are beginning to ascribe functional roles for many
of these lncRNAs, which appear to regulate numerous cell processes
(Rinn and Chang, 2012). Indeed, lncRNAs have emerged as key
regulators of gene expression transcriptionally and post-
transcriptionally, acting through diverse mechanisms such as the
regulation of epigenetic modifications and by acting as scaffolds for
protein complex formation at gene loci (Rinn and Chang, 2012).
lncRNAs display more tissue-specific expression patterns than
protein-coding genes, and cell differentiation during development
is particularly susceptible to experimental loss of lncRNAs
(Derrien et al., 2012; Sauvageau et al., 2013; Fatica and Bozzoni,
2014). For example, lncRNAs play important roles in guiding
limb development. In limb patterning, HOTTIP is required for
specification of mesenchyme condensation sites through promotion
of HOXA gene expression by a cis-regulatory mechanism, and
HOTAIR is now also recognised for a similar trans-acting role in
regulatingHOXD gene expression during skeletal patterning (Wang
et al., 2011; Li et al., 2013).
Little is known about the expression of lncRNAs in cartilage or in
the development of the chondrocyte, the sole cartilage cell type.
Chondrocytes develop from condensations of mesenchymal cells in
a process known as chondrogenesis, which is essential for
development of the endochondral skeleton (Onyekwelu et al.,
2009). During chondrogenesis, cells of the mesenchyme commit to
a chondrocyte differentiation programme then progress through
multiple stages to specify the resting, proliferating and hypertrophic
regions of the growth plate. They also constitute the articular
cartilage at the ends of the long bones. This differentiation is a
coordinated process determined by temporal and spatial expression
of multiple growth factors and dependent on the specific activity of
the HMG-box transcription factor SOX9 (Akiyama, 2008). SOX9
controls the expression of numerous chondrocyte genes, including
its co-factors L-SOX5a and SOX6, and extracellular matrix genes
such as type II collagen and the proteoglycan aggrecan.
Experimental loss of SOX9 abrogates limb development in mice
(Akiyama, 2008; Akiyama and Lefebvre, 2011) and mutations in
the SOX9 coding sequence lead to the skeletal malformation
syndrome campomelic dysplasia (CD) (Foster et al., 1994; Wagner
et al., 1994). DNA alterations around the SOX9 locus can also lead
to CD, highlighting the complex regulatory mechanisms governing
SOX9 expression (Foster et al., 1994; Wagner et al., 1994).
SOX9 is found in a gene desert on chromosome 17, as is common
for developmental transcription factors, surrounded by many
potential regulatory regions. However, the cellular mechanisms
for regulating SOX9 are not fully established. Analyses of CD
patient chromosomal rearrangements and promoter yeast artificial
chromosome transgenes suggest that certain chondrogenesis-
specific enhancers lie in a region between 50 kb and 350 kb
upstream of SOX9 (Foster et al., 1994; Wagner et al., 1994;Received 21 March 2017; Accepted 25 October 2017
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Wunderle et al., 1998; Gordon et al., 2009). SOX9 also specifies the
fate of other lineages, including Sertoli cells, neural stem cells,
pancreas progenitor cells and neural crest, neuronal, glial, heart
valve, gut and kidney cells (Pritchett et al., 2011). Again, tissue-
specific enhancers have been demonstrated to regulate the
expression in some of these tissues (Gordon et al., 2009).
cDNA cloning methods and in silico genome analysis have
established that numerous expressed sequence tags and predicted
transcripts are localised to these enhancer regions upstream of SOX9
but it is unclear which are expressed in particular tissues and whether
any have a functional role in chondrocytes. We established a
chondrocyte repertoire of lncRNAs and confirmed the presence of a
number of transcripts around the SOX9 locus by whole transcriptome
analysis of human articular cartilage RNA by RNA-Seq. We
discovered a novel cartilage-specific 4-exon lncRNA corresponding
to a 3-exon RefSeq transcript LOC102723505 (LINC02095, Ensembl
transcript ENST00000430908) 94 kb upstream of SOX9, which we
termed ROCR (regulator of chondrogenesis RNA). This lncRNA is
required for successful differentiation of mesenchymal stem cells
(MSCs) into chondrocytes where it appears to contribute to SOX9
expression. Thus, we have identified a previously unknown
mechanism of SOX9 regulation involving a chondrocyte-specific
lncRNA.
RESULTS
Human articular chondrocyte lncRNAs
RNA-Seq was performed on normal human hip articular
chondrocyte RNA obtained from female neck of femur (NOF)
fracture patients to establish the adult chondrocyte transcriptome
and its complement of lncRNAs (6 samples; median age=76 years).
Of the 46,087 transcripts identified [fragments per kilobase of exon
per million fragments mapped (FPKM)>1], 813 were annotated as
lncRNAs (Table S2). Examination of cartilage RNA-Seq reads
uploaded to the UCSC genome browser identified processed
transcripts upstream of the SOX9 locus on chromosome 17, with
robust expression of transcripts corresponding to SOX9-AS1 and
LOC102723505 (Fig. 1A), exon/intron boundaries, and evidence of
transcript start and end sites using cap analysis gene expression
(CAGE) and PolyA-Seq data (ENCODE Project Consortium, 2012;
Flicek et al., 2014) (Fig. S1). Proximal to the SOX9 locus transcript,
variants of SOX9-AS1 were detected partially corresponding to
Refseq and predicted Ensembl transcripts. 94 kb upstream of
SOX9 we detected a novel 4-exon variant of an existing 3-exon
RefSeq transcript LOC102723505. We designated the 3-exon
LOC102723505 as ROCR (regulator of chondrogenesis RNA)
transcript variant 1 and the novel 4-exon isoform ROCR transcript
variant 2. We noted the presence of chromatin features of actively
transcribed genes, such as histone H3 lysine 4 trimethylation
(H3K4me3), at the presumed ROCR promoter and enhancer-like
signatures based on histone lysine 27 acetylation (H3K27ac) states
from ENCODE chromatin state data (Fig. 1A, Fig. S1) (Ernst et al.,
2011). The ROCR locus is also notable for the expression of an
additional lncRNA, LINC01152, albeit at very low levels in
cartilage. In comparison with other coding transcripts, SOX9-AS1
and ROCR were moderately expressed in cartilage with FPKM in
the range of 5-15, approximately 10% of the level of SOX9 itself
(Table S2).
We confirmed the expression of SOX9-AS1 and ROCR in human
articular cartilage by qRT-PCR with two assays per transcript
targeted to different exons (Fig. 1B). The ROCR exon1-2 assay
detects only transcript variant 2. Rapid amplification of cDNA ends
(RACE) confirmed the presence of this novel 4-exon 574-base
ROCR transcript (variant 2) in cartilage (Fig. S2). We were also able
to identify this ROCR variant by subsequent analysis of RNA-Seq
data from knee cartilage RNA (Dunn et al., 2016). The majority of
lncRNAs are considered to have nuclear functions and are often
found enriched in the nucleus (Quinodoz and Guttman, 2014). In
contrast to the nuclear enrichment of the small nuclear RNA U2, we
found that both SOX9-AS1 and ROCR were enriched in the
cytoplasm, comparable with the localisation of the SOX9 transcript
itself (Fig. 1C). RNA fluorescence in situ hybridisation (RNA-FISH)
analysis of ROCR in human articular chondrocytes (HACs) was
unsuccessful owing to the relatively low expression and short
transcript sequence, which limited the design of sufficient singly
labelled Stellaris RNA-FISH probes (data not shown). In silico
analysis indicates a lack of coding potential for both SOX9-AS1 and
ROCR, with the existence of only very short open reading frames
(ORF Finder) and codon substitution rates indicative of noncoding
transcripts (CPAT, CPC and PhyloCSF) (Fig. S3). SOX9 is
expressed in a variety of tissues but lncRNAs are reported to be
more tissue specific (Derrien et al., 2012). Accordingly, we
examined expression of SOX9-AS1 and ROCR in additional joint
tissues extracted from osteoarthritis (OA) patients. SOX9-AS1 was
also expressed in synovium and fat pad tissue but ROCRwas largely
undetected indicating that it might be specific to cartilage in the joint
(Fig. 1D).
We further examined transcript expression bioinformatically
using publicly available cell and tissue RNA-Seq databases. Reads
corresponding to SOX9-AS1 were found in numerous cells types in
both Human Protein Atlas (http://www.proteinatlas.org/) and
Illumina BodyMap (ArrayExpress accession: E-MTAB-513;
http://www.ebi.ac.uk/arrayexpress) sequence data (Table S3)
(ENCODE Project Consortium, 2012; Krupp et al., 2012;
Fagerberg et al., 2014; Flicek et al., 2014). Reads corresponding
to the three exons of ROCR transcript variant 1 were found in
pancreas and salivary gland tissue samples in the Human Protein
Atlas RNA-Seq data and in breast tissue samples sequenced in the
Illumina BodyMap data. Consistent with this analysis, further
examination of expression by qRT-PCR across a 20-tissue RNA
panel again identified the presence of SOX9-AS1 transcripts in a
number of tissues (Fig. 1E), albeit in fewer tissues than SOX9 itself
(Fig. 4). In contrast, detection of the novel ROCR transcript variant 2
was limited to chondrocytes alone (Fig. 1F), and the ROCR
transcript variant 1 was additionally detected in brain and testis.
SOX9 locus lncRNA expression in MSC differentiation
Considering the proximity of these transcripts to SOX9 and the
potential chondrocyte specificity of ROCR, we sought to establish
whether SOX9-AS1 and ROCR were regulated during chondrocyte
development. Accordingly, we characterised expression of these
lncRNAs using a robust transwell MSC chondrogenesis method,
which produces a uniform cartilage disc with rapid and substantial
induction of chondrocyte gene expression, albeit including the
expression of chondrocyte hypertrophy genes, thus differing
from articular cartilage (Fig. 2A) (Murdoch et al., 2007). SOX9
expression is upregulated during chondrogenesis. Similarly, the
expression of both SOX9-AS1 and ROCR was induced during
MSC chondrogenesis, paralleling the kinetics of SOX9 expression
(Fig. 2B,C). In contrast, LINC01152, a potential testis-specific
lncRNA (D43770 Genbank ID), was downregulated during MSC
chondrogenesis (Fig. 2D) (Ninomiya et al., 1996). Interestingly,
RACE for MSC RNA identified a further 624-base isoform with an
alternative first exon, which we termed ROCR transcript variant 3
(Fig. S1), situated in a bidirectional promoter locus with LINC01152.
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Fig. 1. See next page for legend.
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MSCs are capable of tri-lineage differentiation into chondrocytes,
osteoblasts and adipocytes, dependent on specific differentiation
factors (Pittenger et al., 1999). We differentiated MSCs into
osteoblasts and adipocytes by established methods and confirmed
the expression of the osteoblast-specific markers alkaline
phosphatase (ALPL) and RUNX2, and the adipocyte-specific
genes adiponectin and FABP4 (Fig. 2E). SOX9 was not
upregulated during osteoblastogenesis or adipogenesis (Fig. 2F).
Similarly, SOX9-AS1 and ROCR were not upregulated during MSC
osteoblastogenesis (Fig. 2G,H). SOX9-AS1 was induced during
MSC adipogenesis, in contrast to ROCR, but not to the level of
chondrogenesis (Fig. 2G).
Role of ROCR in MSC chondrogenesis
SOX9-AS1 and ROCRwere both upregulated during chondrogenesis,
with a profile similar to SOX9; therefore, we addressed their potential
role during MSC chondrogenic differentiation by specific RNA
interference (RNAi)-mediated depletion (Fig. 3A). Reduction of
SOX9-AS1 expression had no effect on development of a cartilaginous
disc (Fig. 3B,C). However, depletion of ROCR prevented disc
formation (Fig. 3B) and caused a significant reduction in wet mass
(Fig. 3C). Consistent with the disruption of disc formation following
ROCR RNAi, matrix deposition in the form of glycosaminoglycan
(GAG) polyanions was also reduced (Fig. 3D). In case the transwell
chondrogenesis method was particularly susceptible to experimental
manipulation, we also performed the traditional pellet chondrogenesis
method and again found that ROCR was required for pellet
development (Fig. 3E). Analysis of extracted sulphated GAG levels
again indicated that ROCR is required for matrix GAG production
(Fig. 3F). In addition, ROCR depletion reduced DNA levels
suggesting it was required for MSC proliferation during the early
stages of chondrocyte differentiation (Fig. 3G) (Murdoch et al., 2007).
Examination of chondrocyte gene expression following SOX9-
AS1 and ROCR RNAi indicated that depletion of ROCR also
significantly abrogated the induction of cartilage extracellular
matrix (ECM) genes including COL2A1 and ACAN (Fig. 4A).
SOX9 is essential for cartilage matrix gene expression, so
we assessed the impact of depletion of SOX9-AS1 and ROCR
at earlier time points in the chondrogenesis time course.
Following ROCR depletion, SOX9 mRNA (Fig. 4B) and protein
(Fig. 4C) was significantly reduced after 1 day of MSC
differentiation, and at even earlier time points the upregulation of
SOX9 expression during MSC chondrogenesis was lost following
ROCR depletion suggesting a crucial role for ROCR in SOX9
induction. During chondrogenesis SOX9 is required for expression
of SOX5 and SOX6, which subsequently cooperate with SOX9 in
directing chondrocyte gene expression (Akiyama et al., 2002).
ROCR depletion also prevented the upregulation of the SOX9 target
genes SOX5 and SOX6, which occurred after SOX9 induction
(Fig. 4D).
To complement the role identified by RNAi for ROCR in MSC
chondrogenesis and SOX9 expression, we also used an LNA
GapmeR approach to deplete cellular ROCR levels (Fig. S5).
Again, the loss of ROCR resulted in a significant reduction in
matrix GAG formation during MSC mini-pellet chondrogenesis
Fig. 1. Expression of lncRNAs from the SOX9 locus. (A) UCSC genome
browser schematic of cartilage RNA-Seq reads aligned to the human genome
with RefSeq gene annotations, Ensembl gene predictions and active H3K27Ac
chromatin marks. Reads are pooled from six neck of femur (NOF) fracture
cartilage donors. Primer locations are indicated by red arrowheads.
(B) Expression of SOX9 locus lncRNAs and SOX9 in RNA extracted from OA
cartilage measured by real-time RT-PCR normalised to 18S. Values are mean
±s.e.m. of data pooled from five separate donors. (C) Subcellular localisation of
SOX9-AS1 and ROCR in comparison with small nuclear RNA U2 and SOX9
mRNA pooled from two OA HAC donors. Values are mean±s.e.m. of ΔCT
between an equal fraction of nuclear and cytoplasmic RNA. (D) Expression of
SOX9-AS1 and ROCR in RNA extracted from OA synovium and joint fat pad.
Values are mean±s.e.m. of data pooled from eight separate synovium and fat
pad donors. (E) Expression of SOX9-AS1 and ROCR in an RNA tissue panel.
Values are the technical mean of data pooled from three donors per tissue.
Fig. 2. Expression of lncRNAs during MSC differentiation. (A) Expression of the indicated genes in RNA extracted from MSCs undergoing chondrogenic
differentiation at the indicated time points between Day 0 and Day 7. (B-D) Expression of SOX9-AS1 (B), ROCR (C) and LINC01152 (D) during MSC
chondrogenic differentiation. (E) Expression of the indicated genes in RNA extracted from MSCs undergoing osteoblastogenic and adipogenic differentiation.
(F-H) Expression of SOX9 (F), SOX9-AS1 (G) and ROCR (H) during MSC osteoblastogenic (Osteo.) and adipogenic (Adipo.) differentiation. Values are mean±
s.e.m. of data pooled from three or four MSC donors.
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with concomitant reduction in SOX9 and matrix gene expression
(Fig. S5). ROCR transcript variants 2 (HAC) and 3 (MSCs) were
cloned and overexpressed in MSCs and HAC by lentiviral
transduction (Fig. S6). Overexpression of ROCR had no effect on
SOX9 expression or induction of the cartilage ECM genes COL2A1
and ACAN duringMSC chondrogenesis (Fig. S6A). Overexpression
of ROCR had no effect on SOX9 expression in HAC (Fig. S6B).
Specificity of ROCR function to chondrogenesis
The above data suggested that ROCR is important for
MSC chondrogenesis. We sought to establish whether the role of
ROCR was specific to chondrocyte development consistent with
its restricted expression profile. Accordingly, we also performed
SOX9-AS1 and ROCR RNAi during MSC osteoblastogenesis
and adipogenesis. Depletion of ROCR during osteoblast
differentiation caused a partial decrease in matrix mineralisation
(Fig. 5A,B), but no significant impact on RUNX2 or ALPL
expression (Fig. 5C). During MSC adipogenesis ROCR depletion
had little effect, whereas SOX9-AS1 depletion partially reduced fat
droplet generation (Fig. 5D,E) and significantly decreased MSC
adipogenic gene expression (Fig. 5F).
SOX9 is essential for chondrogenesis and as lncRNAs can
contribute to the expression of neighbouring genes (Vance and
Ponting, 2014) we reasoned that the primary role of ROCR is to
promote SOX9 expression. Accordingly, overexpression of SOX9
would be expected to rescue the chondrogenesis impairment caused
by ROCR depletion. Lentiviral overexpression of SOX9
successfully enhanced MSC chondrogenesis (Fig. 6A,B). By
overexpressing SOX9 and thereby returning the levels of SOX9 to
those of control (Fig. 6C) the significant reduction of cartilage
matrix GAG levels following depletion of ROCR was almost fully
reversed (Fig. 6D). Reduction of COL2A1 and ACAN by ROCR
depletion was partially reversed by overexpression of SOX9
(Fig. 6E,F), and the levels of L-SOX5a and SOX6 were
completely rescued (Fig. 6G,H).
DISCUSSION
In this study, we established a panel of lncRNAs in normal human
articular cartilage and identified two transcripts upstream of the
SOX9 locus that were upregulated during MSC chondrogenesis.
One of these, ROCR, is a functional cartilage-restricted lncRNA that
appears to be important for chondrocyte differentiation where it
might facilitate the induction of SOX9 itself. This study established
that a lncRNA contributes to SOX9 expression during
differentiation of MSCs into chondrocytes, thereby furthering our
understanding of the key regulatory elements contained upstream of
the SOX9 promoter.
SOX9 is the master transcription factor governing chondrocyte
development, as confirmed by genetic studies (Akiyama et al.,
2002). Regulation of SOX9 occurs at both the transcriptional and
post-transcriptional levels. Phosphorylation of SOX9 regulates its
DNA-binding activity and subcellular localisation, and numerous
Fig. 3. Effect of lncRNA depletion on MSC chondrogenic differentiation. (A-D) MSCs were transfected for 2 days with SOX9-AS1 or ROCR-targeting or
non-targeting control (siCon) siRNA prior to chondrogenic differentiation in hanging transwell inserts. (A)SOX9-AS1 andROCR expression in RNA extracted from
Day 3 and Day 7 chondrogenic discs. Expression is presented as a percentage of non-targeting control levels. (B) Representative Day 3 and 7 chondrogenic
discs. (C) Wet mass of Day 7 chondrogenic discs. (D) Representative Safranin O staining of Day 7 chondrogenic discs. (E-G) MSCs were transfected for 1 day
with ROCR-targeting or non-targeting control siRNA prior to chondrogenic differentiation in a V-bottom 96-well plate. (E) Representative Day 7 chondrogenic
pellets. (F) GAG levels assayed by DMB assay in Day 7 chondrogenic pellets. (G) DNA quantification by PicoGreen assay in Day 7 chondrogenic pellets. Values
are mean±s.e.m. of data pooled from three (A-D) or four (E-G) MSC donors. *P<0.05; ***P<0.001 for lncRNA siRNA versus non-targeting siRNA. Significant
differences between sample groups were assessed by one-way analysis of variance followed by the Bonferroni post-hoc test for multiple comparisons or a
two-tailed Student’s t-test was performed for single comparisons.
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other interactions regulate SOX9 stability and facilitate its
transcriptional activity (Kawakami et al., 2006; Akiyama, 2008).
At the transcriptional level, induction of SOX9 occurs rapidly
during mesenchyme condensation in cartilage development both
in vivo and in vitro (Wright et al., 1995; Sekiya et al., 2002), a
process regulated by an interplay between growth factor signals and
cell-cell interactions (Chimal-Monroy et al., 2003; Yoon et al.,
2005). Our data indicated that during in vitro chondrogenesis a
lncRNA, ROCR, is also important for this process.
lncRNAs in chondrocytes and chondrogenesis
A number of lncRNAs have key roles in stem cell differentiation,
including RMST in neuronal differentiation, Braveheart in cardiac
differentiation and lnc-RAP1-10 in adipocyte differentiation
(Klattenhoff et al., 2013; Ng et al., 2013; Perry and Ulitsky,
2016). Previously identified lncRNAs with a potential role in
cartilage development includeDA125942 and LncRNA-HIT (Maass
et al., 2012; Carlson et al., 2015).DA125942, a lncRNA transcribed
from the CISTR-ACT locus interacts in ciswith PTHLH and in trans
with SOX9 to organise chromatin structure and promote
transcription in cartilage (Maass et al., 2012). No direct role for
the lncRNA in chondrogenesis was explored although the lncRNA
locus was active during mouse limb bud development. LncRNA-
HIT, expressed in mouse limb mesenchyme from the Hoxa gene
locus, is able to bind and regulate DNA regions surrounding a
number of cartilage genes including the Hoxa genes themselves
(Carlson et al., 2015). LncRNA-HIT may activate gene expression
by binding to the p100/CBP complex and it contributes to
micromass chondrogenic differentiation of murine MSCs.
Interestingly, we detected no RNA expression from the CISTR-
ACT locus in our human cartilage RNA-Seq data and the conserved
regions of LncRNA-HIT in human corresponded to an isoform of
HOXA13 with an extended 3′UTR rather than a lncRNA. It is
possible that these lncRNAs might be developmental stage or MSC
specific. The lncRNA DANCR may also promote chondrogenic
differentiation of synovium-derived MSCs in concert with SOX4
Fig. 4. Effect of lncRNA depletion onMSC chondrogenic gene expression. (A) MSCs were transfected for 2 days with SOX9-AS1 orROCR-targeting or non-
targeting control (siCon) siRNA prior to chondrogenic differentiation in hanging transwell inserts. RNA was extracted and expression of the indicated genes
measured by real-time RT-PCR. (B-D) MSCs were transfected for 1 day with SOX9-AS1 orROCR-targeting or non-targeting control siRNA prior to chondrogenic
differentiation in a V-bottom 96-well plate for up to 24 h. RNA and protein was extracted and expression of SOX9mRNA (B) or protein (C) measured by real-time
RT-PCRor immunoblotting, respectively. (D) Expression of L-SOX5a andSOX6. Values aremean±s.e.m. of data pooled from three (A) or four (B-D)MSCdonors.
*P<0.05; **P<0.01; ***P<0.001 for lncRNA siRNA versus non-targeting siRNA. Significant differences between sample groups were assessed by one-way
analysis of variance followed by the Bonferroni post-hoc test for multiple comparisons or a two-tailed Student’s t-test was performed for single comparisons.
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(Zhang et al., 2015). Two recent reviews elaborate on the roles of
these lncRNAs during chondrogenesis (Huynh et al., 2017;
Lefebvre and Dvir-Ginzberg, 2017).
SOX9 is located in a ∼2 Mb gene desert on chromosome 17 in
humans and lncRNA ROCR is expressed from a locus 94 kb
upstream of SOX9. Chromosomal rearrangements within this
region are associated with CD, a skeletal malformation syndrome,
and Pierre Robin sequence (PRS), a craniofacial disorder. Such
disruptions can occur in regions up to and greater than 1 Mb
upstream of SOX9 (Gordon et al., 2009). Characterisation of these
DNA alterations has indicated the presence of enhancer regions
linked to the regulation of SOX9 expression. Breakpoints causing
more severe forms of CD are found more proximal to SOX9
at locations 50-375 kb upstream (Leipoldt et al., 2007). Transgene
and reporter experiments have also indicated that sequences
in these locations are able to drive gene expression in vivo
(Gordon et al., 2009). More recent analysis confirmed the
presence of a murine enhancer element at −70 kb (−62 kb in
human) capable of regulating SOX9 expression in a number of
tissues (Mead et al., 2013), and three further enhancers with
prominent activity in chondrocytes at −84 kb, −195 kb and
−250 kb in mice (Yao et al., 2015).
The ROCR locus sits within these enhancer regions and it is
attractive to suggest that the lncRNA might contribute to the
regulation of SOX9 in vivo. Indeed, functional lncRNAs have been
found to be enriched in genomic regions surrounding key
developmental transcription factors (Ørom et al., 2010; Ulitsky
et al., 2011). In addition to skeletal malformations, patients with CD
often show XY sex reversal, with additional clinical features such as
hearing loss, developmental delay, and occasional heart defects
(Mansour et al., 2002). Consistent with this, genetic ablation of Sox9
in mice disrupts the differentiation of cells in the heart, central
nervous system, testis, pancreas, gut and inner ear (Gordon et al.,
2009). Tissue-specific enhancers regulate the expression of SOX9,
for example the testis enhancer TES at −10 kb, and our analysis
suggested that ROCR is restricted to certain cell types – cartilage,
brain and testis – whereas ROCR variant 2 was only detected in
cartilage. However, our work focussed on RNA extracted from aged
NOF and OA tissue and further work is required to confirm the
expression of ROCR in normal healthy tissues. In combination with
tissue-specific enhancers ROCR might be required for the tightly
coordinated spatiotemporal expression of SOX9 during
development. The expression level of SOX9 in cartilage was one
or two orders of magnitude higher than other tissues (Fig. S4) and
we reasoned that ROCR might also contribute to the magnitude of
SOX9 expression. But, in contrast to its role in chondrogenesis, we
found no significant contribution by ROCR to SOX9 expression
levels in adult articular chondrocytes (Fig. S7A). The role of ROCR
in SOX9 expression might be in response to cues during
chondrogenesis that are not present in cultured HAC, and ROCR
Fig. 5. Effect of lncRNA depletion on MSC osteoblastogenic and adipogenic differentiation. (A-C) MSCs were transfected for 2 days with SOX9-AS1 or
ROCR-targeting or non-targeting control (siCon) siRNA prior to osteoblastogenic differentiation. (A) Representative matrix mineralisation assayed by Alizarin Red
staining after 21 days. (B) Quantification of Alizarin Red staining. (C) RNAwas extracted and expression of the indicated genes at Day 7 measured by real-time
RT-PCR. (D-F) MSCs were transfected for 2 days with SOX9-AS1 or ROCR-targeting or non-targeting control siRNA prior to adipogenic differentiation.
(D) Representative fat droplet generation assayed by Oil Red O staining after 14 days. (E) Quantification of Oil Red O staining. (F) RNA was extracted and
expression of the indicated genes at Day 7 measured by real-time RT-PCR. Values are mean±s.e.m. of data pooled from four MSC donors. *P<0.05; ***P<0.001
for lncRNA siRNA versus non-targeting siRNA. Significant differences between sample groups were assessed by one-way analysis of variance followed by the
Bonferroni post-hoc test for multiple comparisons or a two-tailed Student’s t-test was performed for single comparisons.
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might additionally regulate other genes/proteins. The induction
of both SOX9-AS1 and ROCR paralleled the expression of
SOX9. The activity of the aforementioned −70 kb, −84 kb and
−195 kb SOX9 upstream enhancers is dependent on SOX9 in
differentiated chondrocytes (Yao et al., 2015). Prior to the onset
of chondrogenesis, SOX9 overexpression in MSCs did not
significantly induce ROCR expression (Fig. S7B), but we cannot
rule out the possibility that SOX9 promotes the expression of
ROCR during chondrogenesis, or in adult chondrocytes. Despite
knockdown of ROCR reducing SOX9 expression and cartilage gene
expression in MSCs, reciprocal overexpression of ROCR had no
effect. Overexpression from an artificial plasmid transcription start
site is not entirely analogous to endogenous ROCR expression with
potential alteration to secondary structure formation and cellular
localisation of the RNA.
During skeletogenesis MSC condensation initiates the formation
of multipotent osteochondroprogenitors the lineage fate of which is
then determined by the combination of growth factor signals
received. ROCR is only upregulated during chondrogenesis, not
osteoblastogenesis, suggesting a key role in directing MSCs toward
the chondrocyte lineage. Consistent with this, only a minor impact
of ROCR depletion was observed duringMSC osteoblastogenesis in
contrast to its key requirement during chondrogenesis. During
osteochondroprogenitor differentiation SOX9 has antagonistic
effects on the osteoblast transcription factor RUNX2 in
determining the specific differentiation into their respective
chondrocyte and osteoblast lineages (Zhou et al., 2006). Owing to
the lack of induction of ROCR during osteoblastogenesis, no effect
would be expected. Interestingly, depletion of SOX9-AS1
significantly reduced the expression of adipogenic marker genes,
confirming the efficacy of the SOX9-AS1 depletion and, given the
role of SOX9 in adipogenic differentiation, suggests that SOX9-AS1
also contributes to the differentiation (Stockl et al., 2013).
Putative lncRNA function
We demonstrated that returning SOX9 levels to normal by
overexpression could reverse the impaired chondrogenesis
phenotype caused by depletion of ROCR. This indicated that
Fig. 6. Effect of SOX9 overexpression in
combination withROCR depletion onMSC
chondrogenic differentiation and gene
expression. MSCs were transduced with
SOX9 or control lentivirus (pCDH) for 1 day
then transfected for 1 day with ROCR-
targeting or non-targeting control (siCon)
siRNA prior to chondrogenic differentiation in
a V-bottom 96-well plate. (A) Expression of
SOX9 in only non-targeting control siRNA
pellets at Day 3. (B) GAG levels assayed by
DMB assay in only non-targeting control
siRNA pellets at Day 7. (C) Expression of
SOX9 at Day 3. (D) GAG levels assayed by
DMB assay at Day 7. (E,F) Expression of the
indicated genes at Day 3. (C-F) Expression is
presented as a percentage of non-targeting
control levels for cells transduced with each
virus. Values are mean±s.e.m. of data pooled
from four MSC donors. *P<0.05; **P<0.01;
***P<0.001 for lncRNA siRNA versus non-
targeting siRNA, or for SOX9 versus control
lentivirus where indicated above the chart.
Significant differences between sample
groups were assessed by one-way analysis of
variance followed by the Bonferroni post-hoc
test for multiple comparisons or a two-tailed
Student’s t-test was performed for single
comparisons.
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SOX9 can largely replace ROCR during MSC chondrogenesis as
SOX9 expression was sufficient to produce the cartilage matrix.
Thus, suggesting ROCR is indirectly needed in chondrogenesis to
establish the correct level of SOX9 expression in MSCs during
differentiation. Both silencing and activating roles have been
demonstrated for lncRNAs. XIST establishes X chromosome
inactivation, whereas RMST facilitates SOX2 binding to promoter
regions of neurogenic transcription factors (Vance and Ponting,
2014). In some cases, enhancer regions and the process of
transcription at the lncRNA locus facilitate downstream gene
expression rather than the lncRNA transcript itself (Engreitz et al.,
2016). Our knockdown experiments indicate that ROCR transcript is
functional, and the ROCR locus is considerably upstream from
SOX9 (94 kb), but we cannot rule out the possibility that the ROCR
locus might also function as an enhancer. Many of the identified
functional lncRNA actions occur in the nucleus; however, ROCR
appears to reside more in the cytoplasm than nucleus, indicating an
indirect regulation of SOX9. Our coding analysis indicated that
ROCR is unlikely to code for any significant peptide transcript,
suggesting a role for the RNA in the cytoplasm. A number of
cytoplasmic lncRNAs can regulate mRNA half-life and translation.
TINCR is induced during epidermal differentiation and is required
for stability of differentiation mediators (Kretz et al., 2013) and
antisense Uchl1 lncRNA promotes translation of Uchl1 in mouse
(Carrieri et al., 2012). Other factors also contribute to cartilage gene
expression, such as SP1 and forkhead/winged-helix domain (FOX)
proteins, and this could account for why, despite normal GAG levels,
the expression of COL2A1 and ACAN was not completely restored
during rescue by SOX9, again suggesting an indirect effect of ROCR
(Liu et al., 2016). Or this might simply reflect the difference in
sampling time for gene expression in relation to matrix GAG
measurement. Almost all lncRNAs function through association
with protein partners and, accordingly, RNA pulldown methods are
commonly used to identify such interactions (Yang et al., 2015).
Conservation of lncRNAs across species is low, with less than
10% of all lncRNAs exhibiting regions of conservation compared
with random control regions (Iyer et al., 2015), but there are key
examples of conserved lncRNAs with crucial roles in mouse
development having human counterparts (Sauvageau et al., 2013).
By conducting a homology search for a mouse orthologue of ROCR,
we identified a predicted noncoding RNA transcript (NR_024085/
BC006965) with sequence similarity to exon 2 of ROCR transcript
variant 1 (exon 3 of variants 2 and 3), but little mammalian sequence
conservation in general (Fig. S8). Importantly, the transcripts are in
syntenic regions (containing SOX9) of human chromosome 17q24
and mouse 11qE2. By real-time RT-PCR of mouse cartilage RNA
we have now confirmed the expression of a murine multiple exon
version of ROCR (Fig. S8). Further work will establish whether the
murine transcript is regulated during chondrogenesis and contributes
to chondrocyte development.
Conclusions
The cartilage transcriptome contains many lncRNA transcripts many
of which may have important functions in cartilage biology. Our
identification of cartilage lncRNAs complements the previous
identification of inflammation-induced lncRNAs in chondrocytes
(Pearson et al., 2016). This panel of chondocyte lncRNAs is specific
to human aged hip cartilage and further work should establish the
expression of lncRNAs specific to different zones of articular
cartilage, as well as growth plate cartilage and to establish the
impact of weight bearing, age and disease such as OA. Functional
analysis indicated that ROCR was induced during chondrogenic
differentiation and played an important role in the induction of SOX9
and, as a result, cartilage gene expression. Because SOX9-expressing
cells are progenitors for numerous tissues, identifying chondrocyte-
specific regulatory elements might aid our understanding of
differentiation of chondrocytes from MSCs, which could be
potentially useful in chondrocyte tissue-engineering applications.
MATERIALS AND METHODS
Human tissue isolation
Normal human articular cartilage was obtained from patients undergoing
joint replacement surgery due to intracapsular neck of femur (NOF) fracture.
OA human articular cartilage was obtained from knee joint replacement
operations on patients diagnosed with osteoarthritis (OA). Synovium and
infrapatellar fat pad were also collected from the knee of OA patients. All
tissue was obtained with informed consent and ethics committee approval
from the Newcastle and North Tyneside Health Authority. Scoring,
extraction and patient information for the NOF samples are detailed in Xu
et al. (2012). Briefly, joints were inspected macroscopically and scored by a
blinded experienced orthopaedic surgeon to identify normal NOF cartilage.
Cartilage, all zones, was collected within 2 h of surgery and stored at−80°C
prior to RNA extraction.
Human bone marrow MSC culture
Human bone marrow MSCs (from seven donors, 18-25 years of age)
were isolated from human bone marrow mononuclear cells (Lonza
Biosciences) and cultured and phenotype-tested as described previously
(Barter et al., 2015). Experiments were performed using cells between
passage 2 and 7, and all experiments were repeated with cells from three or
four donors.
Chondrogenic differentiation
MSCs were re-suspended in chondrogenic culture medium consisting of
high-glucose DMEM containing 100 µg/ml sodium pyruvate, 10 ng/ml
TGFβ3, 100 nM dexamethasone, 1× ITS-1 premix, 40 µg/ml proline and
25 µg/ml ascorbate-2-phosphate. MSCs (5×105 in 100 µl medium) were
pipetted onto 6.5-mm diameter, 0.4-µm pore size polycarbonate Transwell
filters (Merck Millipore), centrifuged at 200 g for 5 min, then 0.5 ml of
chondrogenic medium was added to the lower well as described previously
(Murdoch et al., 2007; Barter et al., 2015). For V-bottom 96-well-plate
pellet chondrogenesis, 5×104 MSCs in 150 µl chondrogenic medium were
pipetted into a UV-sterilised V-bottom 96-well plate and centrifuged at
500 g for 5 min. Media were replaced every 2 or 3 days for up to 7 days.
Osteoblast and adipocyte differentiation
MSCs were plated in 96-well plates at a density of 15,000/cm2 for 24 h then
media were replaced with either osteoblastogenic culture medium consisting
of DMEM supplemented with 10% (v/v) foetal bovine serum (FBS), 10 mM
β-glycerol phosphate, 100 nM dexamethasone and 50 µg/ml ascorbic acid
2-phosphate, or adipogenic culture medium consisting of DMEM
supplemented with 10% FBS, 1 μM dexamethasone, 10 μg/ml insulin,
0.5 mM IBMX, 60 μM indomethacin, 2 μM rosiglitazone and 20 nM IGF-1
(R&D Systems) (all Sigma unless specified). Media were replaced every 3
or 4 days. Seven days of differentiation was sufficient to assess gene
expression changes in markers of differentiation. Cells were cultured for
21 days in osteoblastogenic medium to achieve fully mineralised cultures,
and for 14 days in adipogenic medium for lipid production.
Histology and biochemical analysis
Transwell discs were stained as described (Barter et al., 2015). Chondrogenic
pellets and transwell discs were digested with papain (10 U/ml) at 60°C
(Murdoch et al., 2007). The sulphated glycosaminoglycan (GAG) content was
measured by 1,9-dimethylmethylene blue (DMB) binding (Sigma)
using chondroitin sulphate (Sigma) as standard (Farndale et al., 1982),
and the DNA content was measured with PicoGreen (Invitrogen) intercalating
dye following the manufacturer’s instructions. Cells undergoing osteoblast
differentiation were fixed in 70% cold ethanol (5 min, −20°C). After drying
the wells to reveal calcium-rich mineralisation deposits, the cells were
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incubated at room temperature with a solution of Alizarin Red (Sigma)
(40 mM, pH 4.2) for 20-30 min. For quantification the staining was extracted
with 10% (w/v) cetylpyridinium (Sigma) solubilised in 10 mM sodium
phosphate buffer (pH 7) and the absorbance measured at 620 nM. Cells
undergoing adipogenesis were fixed with formalin for 1 h, washed with
distilled water and 60% isopropanol then dried. To reveal the presence of lipid
droplets, the cells were stained with a 21% (w/v) solution of Oil Red O for
10 min. For quantification the staining was extracted with 100% isopropanol
and the absorbance measured at 500 nM. Stained cells were washed with
distilled water prior to image acquisition.
RNA extraction and real-time reverse transcription PCR
Cartilage, synovium and fat pad samples were ground into powder and
homogenised using Invitrogen TRIzol Reagent (Life Technologies) prior to
RNA purification using the Qiagen RNeasy mini kit (Qiagen) essentially as
previously described (Xu et al., 2012). MSC chondrogenic transwell discs
were disrupted in TRIzol (for real-time RT-PCR) using a small disposable
plastic pestle and an aliquot of Molecular Grinding Resin (G-Biosciences/
Genotech). MSC chondrogenesis pellets were disrupted in Ambion Cells-
to-cDNA II Cell Lysis buffer (Life Technologies). Total RNA was then
extracted and converted to cDNA using MMLV reverse transcriptase
(Invitrogen) and TaqMan real-time RT-PCR was performed and gene
expression levels were calculated as described previously (Barter et al.,
2010). Nuclear and cytoplasmic RNA fractions were separated using the
CelLytic NuCLEAR Extraction Kit (Sigma) supplemented with
RNaseOUT ribonuclease inhibitor (Life Technologies). All values are
presented as the mean±s.e.m. of replicates in pooled experiments. lncRNA
real-time RT-PCR amplification products were sequence verified by cloning
into the pCR4-TOPO vector (Life Technologies). The Ambion FirstChoice
Human Total RNA Survey Panel (AM6000) contains pools of total RNA
from 20 different normal human tissues, each pool consisting of RNA from
at least three tissue donors. Primer sequences are listed in Table S1.
RNA-Seq and analysis
RNA integrity was checked using an Agilent Bioanalyzer 2100 (Agilent
Technologies); RNA samples with an RNA Integrity Number (RIN)≥7
were selected. For each sample, cDNA libraries were prepared for
sequencing from 5 µg of total RNA using Illumina TrueSeq mRNA kits
with the manufacturers’ protocols. mRNA-enriched RNA was initially
purified using polydT oligo-attached magnetic beads using two rounds of
purification. During the second elution the RNA was fragmented and
random primed for cDNA synthesis. After the addition of a single ‘A’, base
adaptors were annealed, and the products purified and enriched with PCR to
create a final cDNA library. No indexing (barcoding) was performed.
Library DNA size was checked using the Agilent Bioanalyzer and
quantified using the Kapa Library Quant kits (Kapa Biosciences). A
7.5 pM solution of each library was loaded onto each lane of an Illumina
Genome Analyzer IIa and 78-base paired-end sequencing performed. On
average, each sample gave 28 million read pairs. Sample quality control was
performed using FastQC (Babraham Bioinformatics). Reads were aligned to
the reference genome using TopHat, specifying mate inner distance (mean
inner distance between mate pairs) and standard deviation for each sample
(Trapnell et al., 2012). Mapped reads were then assembled into complete
transcripts using the splice junction mapping tool Cufflinks, with option –G,
which utilises the Ensembl reference gene track to improve mapping.
Cuffmerge was used to merge the assembled transcripts into a consensus
gene track from the all of the mapped samples. Ensembl transcript biotypes
were applied to identify lncRNAs (biotype lincRNA). The coding potential
of lncRNAs was assessed with ORFfinder (NCBI), Coding Potential
Assessment Tool (CPAT), Coding Potential Calculator (CPC) and
PhyloCSF (Kong et al., 2007; Lin et al., 2011; Wang et al., 2013). RNA
sequencing data have been uploaded to Gene Expression Omnibus (GEO).
RNA-mediated interference, GapmeR transfection and lentiviral
transduction
For siRNA transfection, 50 nM siRNAwas transfected into 40-50% confluent
MSCs using Dharmafect 1 lipid reagent (Thermo Fisher). 50 nM siRNA
Dharmacon siGENOME and ON-TARGET+ siRNA (Thermo Fisher
Scientific) were used to target SOX9-AS1 and ROCR. Depletion of gene-
specificmRNA levels was calculated by comparison of expression levels with
cells transfected with 50 nM siCONTROL (non-targeting siRNA 2; 001210-
02, Dharmacon). For GapmeR transfection, 100 nM Antisense LNA
GapmeR (Exiqon) targeting ROCR or non-targeting control (Negative
Control A; 300610) were transfected as for siRNAs. siRNA and GapmeR
sequences are listed in Table S1. pCDH-EF1-MCS-IRES-copGFP lentivirus
expression vector (System Biosciences) containing SOX9 was generated by
cloning SOX9 from pUT-FLAG-SOX9 (Lefebvre et al., 1997). pCDH-EF1-
MCS lentivirus expression vectors containing ROCR transcript variant 2 and
transcript variant 3 were generated by cloning gBlock gene fragments (IDT)
containing the sequences specified in Fig. S1. Lentiviruses expressing SOX9,
ROCR or control empty vector lentivirus were generated by transfecting
HEK-293T cells with pCDH plasmids, together with packaging plasmids
pCMV-VSV-G (Addgene plasmid #8454, deposited by Bob Weinberg) and
psPAX2 (Addgene plasmid #12260, deposited by Didier Trono). The virus-
containing culture media were collected every 24 h for 3 days and
concentrated (10×) with Clontech Lenti-X Concentrator into PBS (Takara).
MSCs and HAC were transduced with the lentivirus-containing PBS plus
8 μg/ml polybrene. A Promega CytoTox 96 cytotoxicity assay was used to
assess cell viability following siRNA treatment (Fig. S9).
Rapid amplification of cDNA ends (RACE)
5′RACEwas performed on RNA extracted from human articular cartilage or
MSCs using the Invitrogen 5′ RACE System for Rapid Amplification of
cDNA Ends (Life Technologies). Primer sequences are listed in Table S1.
PCR amplification products were electrophoresed on agarose gels, cloned
into the pCR4-TOPO vector and Sanger sequenced. The sequences have
been uploaded to GenBank.
Immunoblotting
Lysates from MSCs were prepared as described previously (Barter et al.,
2010). Lysates were immunoblotted with the following antibodies: SOX9
(AB5535, 1:2000) and GAPDH (AB2302, 1:40,000) (both Merck
Millipore). Secondary anti-rabbit antibodies were from Dako and
chemiluminescent images were captured using a G:BOX Chemi system
(Syngene).
Statistical analysis
Data from each donor were individually analysed for gene expression and
the values from each donor were then pooled to generate the mean±s.e.m.
Significant differences between sample groups were assessed by one-way
analysis of variance followed by the Bonferroni post-hoc test for multiple
comparisons or by two-tailed Student’s t-test for single comparisons.
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